145 related articles for article (PubMed ID: 22755303)
1. A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center.
Khan MA; Masood N; Husain N; Ahmad B; Aziz T; Naeem A
J Pak Med Assoc; 2012 May; 62(5):430-4. PubMed ID: 22755303
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic cardiotoxicity associated with 5-fluorouracil.
Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
[TBL] [Abstract][Full Text] [Related]
4. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
5. [Cardiotoxicity of 5-fluorouracil].
Pan L; Yang X; Song H
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
[TBL] [Abstract][Full Text] [Related]
6. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic 5-fluorouracil-induced sinus bradycardia.
Lee AD; McKay MJ
Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
10. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Deboever G; Hiltrop N; Cool M; Lambrecht G
Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
[TBL] [Abstract][Full Text] [Related]
12. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
Saif MW; Garcon MC; Rodriguez G; Rodriguez T
In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
[TBL] [Abstract][Full Text] [Related]
13. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
[TBL] [Abstract][Full Text] [Related]
14. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil.
Talapatra K; Rajesh I; Rajesh B; Selvamani B; Subhashini J
J Cancer Res Ther; 2007; 3(3):169-71. PubMed ID: 18079582
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
[TBL] [Abstract][Full Text] [Related]
16. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
[TBL] [Abstract][Full Text] [Related]
17. [Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].
Gamelin E; Gamelin L; Larra F; Turcant A; Alain P; Maillart P; Allain YM; Minier JF; Dubin J
Bull Cancer; 1991; 78(12):1147-53. PubMed ID: 1786427
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for cardiotoxicity during fluorouracil and cisplatin combination chemotherapy].
Kaise M; Yoshino M; Nagai H; Sasaki S; Okura Y; Maruyama Y
Gan To Kagaku Ryoho; 2014 May; 41(5):601-4. PubMed ID: 24917005
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity of 5-fluorouracil.
Collins C; Weiden PL
Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
